[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342957-105":59,"doc-detail-342957-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cancer-associated-fibroblasts-cafs-gene-signatures-predict-outcomes-in-breast-and-prostate-tumor-patients","Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients","","Tumor-derived RNA expression signatures are used to improve outcome prediction and treatment decisions for breast and prostate cancers, yet the clinical significance of cancer-associated fibroblasts (CAFs)-related gene signatures remains insufficiently defined. RNA-seq profiles CAFs isolated from breast and prostate tumor patients, intersected CAF differential genes with public bulk datasets, and applied pathway enrichment. K-means clustering, survival analysis, and decision-tree validation with boosting stratified cohorts into high/low expression groups.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-associated-fibroblasts-cafs-gene-signatures-predict-outcomes-in-breast-and-prostate-tumor-patients/342957/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-associated-fibroblasts-cafs-gene-signatures-predict-outcomes-in-breast-and-prostate-tumor-patients/342957.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about CAFs in breast and prostate cancers?","Question",{"text":112,"@type":113},"It evaluates whether gene signatures derived from cancer-associated fibroblasts (CAFs) can predict patient outcomes and improve prognostic stratification in breast and prostate tumors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were CAFs gene signatures constructed in the study?",{"text":117,"@type":113},"RNA-seq was used to profile CAF transcriptomes from breast and prostate tumor patients, differential genes were intersected with public bulk RNA-seq datasets, and K-means clustering generated CAFs-related signatures for each cancer type.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings from the gene signatures?",{"text":121,"@type":113},"The breast CAF signature included 8 pro-metastatic genes and high expression associated with worse clinical outcomes, while the prostate CAF signature included 11 immune-associated genes where low expression predicted poor survival, with high accuracy in independent cohorts.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342957,1790231954,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Talia et al. Journal of Translational Medicine (2024) 22:597  \n[https://doi.org/10.1186/s12967-024-05413-2](https://doi.org/10.1186/s12967-024-05413-2)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nCancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients  \nMariannaTalia 1†, Eugenio Cesario2†, Francesca Ciril lo 1†, Domenica Scordamaglia 1, Marika Di Dio 1, Azzurra Zicarelli 1, Adel ina Assunta Mondino 1, Maria Antonietta Occhiuzzi 1, Ernestina Marianna De Francesco3, Antonino Belfiore4, Anna Maria Miglietta5, Michele Di Dio6, Carlo Capal bo 1,7, Marcello Maggiolini 1*† and Rosamaria Lappano 1*†  \nAbstract  \nBackground Over the last two decades, tumor-derived RNA expression signatures have been developed for the two most commonly diagnosed tumors worldwide, namely prostate and breast tumors, in order to improve both outcome prediction and treatment decision-making. In this context, molecular signatures gained by main components of the tumor microenvironment, such as cancer-associated fibroblasts (CAFs), have been explored as prognostic and therapeutic tools. Nevertheless, a deeper understanding of the significance of CAFs-related gene signatures in breast and prostate cancers still remains to be disclosed.  \nMethods RNA sequencing technology (RNA-seq) was employed to profile and compare the transcriptome of CAFs isolated from patients affected by breast and prostate tumors. The differential ly expressed genes (DEGs) characterizing breast and prostate CAFs were intersected with data from public datasets derived from bulk RNA-seq profiles of breast and prostate tumor patients. Pathway enrichment analyses allowed us to appreciate the biological significance of the DEGs. K-means clustering was applied to construct CAFs-related gene signatures specific for breast and prostate cancer and to stratify independent cohorts of patients into high and low gene expression clusters. Kaplan-Meier survival curves and log-rank tests were employed to predict differences in the outcome parameters of the clusters of patients. Decision-tree analysis was used to validate the clustering results and boosting calculations were then employed to improve the results obtained by the decision-tree algorithm.  \nResults Data obtained in breast CAFs allowed us to assess a signature that includes 8 genes (ITGA11, THBS1,  \nFN1, EMP1, ITGA2, FYN, SPP1, and EMP2) belonging to pro-metastatic signaling routes, such as the focal adhesion pathway. Survival analyses indicated that the cluster of breast cancer patients showing a high expression of the aforementioned genes displays worse clinical outcomes. Next, we identified a prostate CAFs-related signature that  \n†MariannaTalia, Eugenio Cesario, Francesca Ciril lo, Marcello  \nMaggiolini and Rosamaria Lappano contributed equally to this work.  \n*Correspondence:  \nMarcello Maggiolini [marcello.maggiolini@unical.it](marcello.maggiolini@unical.it)[ ](marcello.maggiolini@unical.it)Rosamaria Lappano[rosamaria.lappano@unical.it](rosamaria.lappano@unical.it)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativeco","cbCaieyKc8D3BqAO","https://ap.wps.com/l/cbCaieyKc8D3BqAO","pdf",5171910,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What question does the study address about CAFs in breast and prostate cancers?\",\"answer\":\"It evaluates whether gene signatures derived from cancer-associated fibroblasts (CAFs) can predict patient outcomes and improve prognostic stratification in breast and prostate tumors.\"},{\"question\":\"How were CAFs gene signatures constructed in the study?\",\"answer\":\"RNA-seq was used to profile CAF transcriptomes from breast and prostate tumor patients, differential genes were intersected with public bulk RNA-seq datasets, and K-means clustering generated CAFs-related signatures for each cancer type.\"},{\"question\":\"What were the key findings from the gene signatures?\",\"answer\":\"The breast CAF signature included 8 pro-metastatic genes and high expression associated with worse clinical outcomes, while the prostate CAF signature included 11 immune-associated genes where low expression predicted poor survival, with high accuracy in independent cohorts.\"}]","Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients | PDF",1790049086,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6be8e7f9297e7b64d5587c0237df3664.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a7c4fa4da25abae43855e7f0445f047.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a801b620fd3f4b53abaf534907062b14.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a285fff9541dd3592c528830a6a883f6.webp",980,1306]